Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.006
▾0.00 (0.00%)
Last trade: 29/05, 10:34AM
Market cap
$14.64m
Market closed
Investor Presentations
Principal Activity
Alterity Therapeutics Limited (ATH, formerly PBT) is an Australian biotechnology company which is developing first-in-class therapies to treat neurodegenerative disease. Lead drug candidate, ATH434, has demonstrated efficacy in several animal models of Parkinsonian disorders and is being evaluated in clinical trials. Formerly known: Prana Biotechnology Ltd (PBT)
Address
Level 3/62 Lygon St, Carlton VIC 3053, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.006
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia